Clinical Trials Directory

Trials / Completed

CompletedNCT02321631

Efficacy of EPA-enriched Supplement in Malnourished Head and Neck Cancer Patients Undergone Surgery

Efficacy of EPA-enriched Supplement Compared With Standard Formula on Body Weight Changing in Malnourished Head and Neck Cancer Patients Undergone Surgery: A Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Prince of Songkla University · Academic / Other
Sex
All
Age
15 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the effects of EPA-enriched supplement compared with conventional supplement in malnourished head and neck cancer patients undergone surgery. Primary outcome is perioperative weight changing.

Detailed description

To study the effects of EPA-enriched supplement compared with conventional supplement in malnourished head and neck cancer patients undergone surgery. The patients are divided into 2 groups receiving the different formula supplements. The both supplements are isocaloric. The patients receive the supplement for 3 weeks (1 week prior to surgery and 2 weeks post surgery) Primary outcome is perioperative weight changing. Secondary outcomes are body compositions, hospital stay days, complication and co-morbidity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEPA-enriched supplementEPA-enriched supplement is given to the patients for 3 weeks (1 week prior to surgery and 2 weeks post surgery). The supplement composes of 2.2 gm of EPA and 630 kcal daily.
DIETARY_SUPPLEMENTstandard formula supplementThe standard formula supplement is given to the patients for 3 weeks (1 week prior to surgery and 2 weeks post surgery). The supplement is 630 kcal daily without EPA.

Timeline

Start date
2015-01-01
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2014-12-22
Last updated
2020-03-04

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02321631. Inclusion in this directory is not an endorsement.